Cardiovascular risk reduction following metabolic and bariatric surgery

Wayne J English1, Matthew D Spann1, Chetan V Aher1

  • 1Department of Surgery, Vanderbilt University Medical Center, Nashville, TN, USA.

Insights

Obesity significantly increases cardiovascular disease (CVD) risk. Metabolic and bariatric surgery effectively reduces body weight and associated CVD risk factors like hypertension and diabetes.

Area of Science:

  • Cardiology
  • Metabolic Surgery
  • Obesity Medicine

Background:

  • Cardiovascular disease (CVD) is a leading global cause of death.
  • Obesity is a major, modifiable risk factor for CVD development.
  • Obesity-related conditions like hypertension (HTN), dyslipidemia, and diabetes mellitus (DM) exacerbate CVD risk.

Purpose of the Study:

  • To review current CVD risk models.
  • To elucidate the mechanisms linking obesity to cardiovascular risk.
  • To compare CVD risk reduction across various metabolic and bariatric procedures.

Main Methods:

  • Literature review of CVD risk models.
  • Analysis of pathophysiological mechanisms of obesity-related CVD.
  • Comparative review of bariatric surgery outcomes on CVD risk factors.

Main Results:

  • Metabolic and bariatric surgery leads to substantial and sustained weight loss.
  • Significant reductions in key CVD risk factors (HTN, DM, dyslipidemia) are observed post-surgery.
  • Different surgical procedures show varying degrees of efficacy in risk factor reduction.

Conclusions:

  • Weight reduction through metabolic and bariatric surgery is a powerful strategy for mitigating CVD risk in obese patients.
  • Understanding CVD risk models and surgical mechanisms is crucial for patient management.
  • Personalized surgical approaches may optimize cardiovascular outcomes in individuals with obesity.

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
202
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
530
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
181
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
263
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
257
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
3.7K